We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home Companiesicad inc

icad inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
None USD 0.00(0%)
Last update at 2025-08-21T20:04:27.089041Z
Market Cap
40.61M

Momentum Score

…

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
1.14
Low
3.97
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
17.32M
Revenue Per Share
0.68
Gross Profit TTM
20.11M
Debt / Equity
0.01
ROE
-20.52%
Net Debt
-21.21M
ROCE
-40.18%
Diluted EPS TTM
-0.19

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -13.77M -11.24M -17.57M -13.51M -8.97M
Net income -13.66M -11.24M -17.61M -13.55M -9.02M
Selling general administrative 11.23M 10.41M 9.12M 7.44M 9.12M
Selling and marketing expenses 13.69M 15.13M 13.31M 13.63M 8.69M
Gross profit 19.81M 24.24M 21.35M 24.23M 19.43M
Reconciled depreciation 0.52M 0.56M 0.58M 0.67M 0.71M
Ebit -13.93M -10.73M -9.39M -6.40M -8.47M
Ebitda -13.24M -10.16M -16.18M -12.05M -7.76M
Depreciation and amortization 0.69M 0.57M -6.79M -5.65M 0.71M
Non operating income net other - -0.37M - -6.33M -0.34M
Operating income -13.93M -10.73M -9.39M -6.40M -8.13M
Other operating expenses 41.87M 44.37M 39.09M 37.74M 33.75M
Interest expense 0.01M 0.14M 0.48M 0.78M 0.50M
Tax provision -0.12M 0.00M 0.04M 0.04M 0.04M
Interest income 0.21M 0.01M 0.10M 0.34M 0.11M
Net interest income 0.20M -0.14M -0.48M -0.44M -0.84M
Income tax expense -0.12M 0.00M 0.04M 0.04M 0.04M
Total revenue 27.94M 33.64M 29.70M 31.34M 25.62M
Total operating expenses 33.74M 34.98M 30.74M 30.62M 27.56M
Cost of revenue 8.13M 9.39M 8.34M 7.11M 6.19M
Total other income expense net 0.16M -0.51M -8.18M -7.11M 0.11M
Net income from continuing ops -13.66M -11.24M -17.61M -13.55M -9.02M
Net income applicable to common shares -13.66M -11.24M -17.61M -13.55M -9.02M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 41.42M 51.70M 62.19M 55.58M 41.75M
Intangible assets 0.15M 0.48M 0.68M 0.89M 1.18M
Other current assets 0.70M 2.64M 2.96M 1.95M 1.45M
Total liab 8.00M 16.80M 15.67M 25.06M 36.68M
Total stockholder equity 33.42M 34.90M 46.52M 30.52M 5.07M
Deferred long term liab - - 0.45M - 0.36M
Other current liab 2.45M 4.68M 5.64M 7.04M 6.59M
Common stock 0.27M 0.25M 0.25M 0.24M 0.20M
Capital stock 0.27M 0.25M 0.25M 0.24M 0.20M
Retained earnings -271.68M -266.84M -253.18M -241.94M -224.32M
Other liab - - 0.45M 0.27M 0.36M
Good will 8.36M 8.36M 8.36M 8.36M 8.36M
Other assets 0.00M 0.18M 0.90M 3.29M 0.05M
Cash 21.67M 21.31M 34.28M 27.19M 15.31M
Total current liabilities 6.75M 13.45M 14.96M 16.75M 18.84M
Current deferred revenue 3.40M 6.22M 5.65M 6.12M 5.25M
Net debt -21.21M -17.93M -33.13M -18.43M 7.18M
Short term debt 0.19M 0.58M 0.89M 0.73M 5.01M
Short long term debt - - - - 4.25M
Short long term debt total 0.46M 3.38M 1.16M 8.76M 22.49M
Other stockholder equity 304.83M 301.48M 299.44M 272.22M 229.20M
Property plant equipment - 4.43M 1.94M 2.50M 0.55M
Total current assets 29.68M 38.24M 50.31M 42.30M 29.20M
Net tangible assets - 26.06M 37.47M 21.27M -4.47M
Net receivables 6.39M 8.90M 8.89M 10.03M 9.82M
Long term debt - - - 6.96M 2.00M
Inventory 0.92M 5.39M 4.17M 3.14M 2.61M
Accounts payable 0.71M 1.97M 2.78M 2.87M 1.99M
Accumulated other comprehensive income 0.00M - - - -6.51M
Common stock total equity - - 0.25M 0.24M 0.20M
Retained earnings total equity - - -253.18M - -224.32M
Treasury stock - - -1.42M - -1.42M
Non currrent assets other 0.69M 0.07M 0.90M 1.53M 0.05M
Non current assets total 11.74M 13.46M 11.88M 13.28M 12.55M
Capital lease obligations 0.46M 3.38M 1.16M 1.80M 1.84M
Long term debt total - - - - 3.84M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.84M -0.53M -0.59M -0.47M -0.31M
Change to liabilities - -0.81M -0.38M 1.66M 0.94M
Total cashflows from investing activities - -0.53M -0.59M -0.47M -0.31M
Net borrowings - - -7.36M 0.32M -0.02M
Total cash from financing activities 2.05M 0.35M 17.09M 19.33M 10.54M
Change to operating activities - -0.58M -1.73M -1.60M 1.28M
Net income -7.01M -13.66M -11.24M -17.61M -13.55M
Change in cash 0.36M -12.97M 7.10M 11.87M 3.13M
Begin period cash flow 21.31M 34.28M 27.19M 15.31M 12.19M
End period cash flow 21.67M 21.31M 34.28M 27.19M 15.31M
Total cash from operating activities -4.96M -12.79M -9.41M -6.99M -7.11M
Issuance of capital stock 1.84M 0.00M 23.23M 18.29M 9.35M
Depreciation 0.41M 0.52M 0.56M 0.58M 0.67M
Other cashflows from investing activities - - -0.02M - -0.01M
Dividends paid - - 0.06M 0.27M 0.20M
Change to inventory 1.49M -1.22M -1.03M -0.53M -1.02M
Change to account receivables 0.42M -0.74M 0.97M -0.30M -3.48M
Sale purchase of stock - 0.15M -0.06M 0.27M -0.20M
Other cashflows from financing activities 0.00M 0.35M -0.06M 8.46M 3.60M
Change to netincome - - 3.43M 10.74M 6.44M
Capital expenditures 1.26M 0.53M 0.59M 0.47M 0.31M
Cash and cash equivalents changes - - 7.10M - 3.13M
Change in working capital 0.09M -2.67M -2.17M -0.77M -2.28M
Stock based compensation 1.32M 1.69M 2.78M 2.84M 1.17M
Other non cash items 0.21M 1.45M 0.67M 7.98M 6.88M
Free cash flow -6.23M -13.32M -9.99M -7.46M -7.41M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

icad inc

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

98 Spit Brook Road, Nashua, NH, United States, 03062

603 882 5200

https://www.icadmed.com

67

Name Title Year Born
Ms. Stacey M. Stevens Pres, CEO & Director 1968
Mr. Jonathan Go Chief Technology Officer 1963
Mr. Michael S. Klein Exec. Director 1954
Mr. Stephen P. Sarno Interim Chief Financial Officer 1967
Ms. Annette L. Heroux VP of Admin. 1957
Mr. Anthony Takazawa Director of Investor Relations NA
Brian Testa Chief People Officer NA
Mr. Jeffrey Sirek Chief Commercial Officer NA
Ms. Dana R. Brown President, CEO & Executive Chair 1965
Mr. Eric Lonnqvist Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…